Identification of Cuproptosis-Related Genes in Nonalcoholic Fatty Liver Disease

被引:11
|
作者
Wu C. [1 ]
Liu X. [1 ]
Zhong L. [1 ]
Zhou Y. [1 ,2 ]
Long L. [3 ]
Yi T. [4 ]
Chen S. [1 ]
Li Y. [1 ]
Chen Y. [1 ]
Shen L. [1 ]
Zeng Q. [1 ]
Tang S. [1 ]
机构
[1] Department of Gastroenterology, The First Affiliated Hospital, Jinan University, Guangdong, Guangzhou
[2] Department of Gastroenterology, The First Affiliated Hospital, Gannan Medical University, Ganzhou
[3] Department of Gastroenterology, The Fifth Affiliated Hospital, Guangzhou Medical University, Guangdong, Guangzhou
[4] Department of Oncology, Affiliated Hospital of YouJiang Medical University for Nationalities, Guangxi, Baise
关键词
461.2 Biological Materials and Tissue Engineering - 461.6 Medicine and Pharmacology - 461.9 Biology - 804.1 Organic Compounds - 922.2 Mathematical Statistics;
D O I
10.1155/2023/9245667
中图分类号
学科分类号
摘要
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent hepatic pathology worldwide. However, the precise molecular mechanisms for NAFLD are still not sufficiently explained. Recently, a new mode of cell death (cuproptosis) is found. However, the relationship between NAFLD and cuproptosis remains unclear. We analyzed three public datasets (GSE89632, GSE130970, and GSE135251) to identify cuproptosis-related genes stably expressed in NAFLD. Then, we performed a series of bioinformatics analyses to explore the relationship between NAFLD and cuproptosis-related genes. Finally, 6 high-fat diet- (HFD-) induced NAFLD C57BL/6J mouse models were established to carry out transcriptome analysis. The results of gene set variation analysis (GSVA) revealed that the cuproptosis pathway was abnormally activated to a certain degree (p=0.035 in GSE89632, p=0.016 in GSE130970, p=0.22 in GSE135251), and the principal component analysis (PCA) of the cuproptosis-related genes showed that the NAFLD group separated from the control group, with the first two principal components accounting for 58.63%-74.88% of the variation. Among three datasets, two cuproptosis-related genes (DLD and PDHB, p<0.01 or 0.001) were stably upregulated in NAFLD. Additionally, both DLD (AUC=0.786-0.856) and PDHB (AUC=0.771-0.836) had favorable diagnostic properties, and the multivariate logistics regression model further improved the diagnostic properties (AUC=0.839-0.889). NADH, flavin adenine dinucleotide, and glycine targeted DLD, and pyruvic acid and NADH targeted PDHB in the DrugBank database. The DLD and PDHB were also associated with clinical pathology, especially with steatosis (DLD, p=0.0013-0.025; PDHB, p=0.002-0.0026) and NAFLD activity score (DLD, p=0.004-0.02; PDHB, p=0.003-0.031). What is more, DLD and PDHB were correlated with stromal score (DLD, R=0.38, p<0.001; PDHB, R=0.31, p<0.001) and immune score (DLD, R=0.26, p<0.001; PDHB, R=0.27, p<0.001) in NAFLD. Furthermore, Dld and Pdhb were also significantly upregulated in the NAFLD mouse model. In conclusion, cuproptosis pathways, especially DLD and PDHB, could be potential candidate genes for NAFLD diagnostic and therapeutic options. © 2023 Chutian Wu et al.
引用
收藏
相关论文
共 50 条
  • [41] Identification and Characterization of Nonalcoholic Fatty Liver Disease
    Goldshtein, Inbal
    Chodick, Gabriel
    Kochba, Ilan
    Gal, Nitsan
    Webb, Muriel
    Shibolet, Oren
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (08) : 1887 - 1889
  • [42] Identification of Glucose Metabolism-Related Genes in the Progression from Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma
    Wang, Siyuan
    Li, Yiling
    Liu, Ning
    Shen, Wei
    Xu, Wenhao
    Yao, Peng
    GENETICS RESEARCH, 2022, 2022
  • [43] Comprehensive analysis of cuproptosis genes and cuproptosis-related genes as prognosis factors in esophageal squamous cell carcinoma
    Wu, Zhisheng
    Huang, Zexin
    Zhou, Xiao
    Gao, Chenmeng
    Peng, Zhongte
    Zheng, Xiaoqi
    Zhang, Yifan
    Du, Zepeng
    Wu, Bingli
    GENOMICS, 2023, 115 (06)
  • [44] Liver transcriptional profile of atherosclerosis-related genes in human nonalcoholic fatty liver disease
    Sookoian, Silvia
    Fernandez Gianotti, Tomas
    Soledad Rosselli, Maria
    Burgueno, Adriana L.
    Castano, Gustavo O.
    Pirola, Carlos J.
    ATHEROSCLEROSIS, 2011, 218 (02) : 378 - 385
  • [45] In vitro identification of nonalcoholic fatty liver disease-related protein hnRNPM
    Takino, Jun-ichi
    Nagamine, Kentaro
    Takeuchi, Masayoshi
    Hori, Takamitsu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (06) : 1784 - 1793
  • [46] A novel cuproptosis-related genes model in breast cancer prognosis
    Zheng, Qun
    Shi, Shuai
    Zhang, Ning
    Chen, Haohao
    MEDICINE, 2023, 102 (31) : E34507
  • [47] The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis
    Zhao, Xueying
    Chen, Jin
    Yin, Shangqi
    Shi, Jingren
    Zheng, Mei
    He, Chaonan
    Meng, Huan
    Han, Ying
    Han, Jinyu
    Guo, Jingjing
    Yuan, Zhengrong
    Wang, Yajie
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [48] Cuproptosis-related genes are involved in immunodeficiency following ischemic stroke
    Li, Jinshi
    Yu, Cong
    Shu, Liang
    Ren, Dabin
    Zheng, Ping
    ARCHIVES OF MEDICAL SCIENCE, 2024, 20 (01) : 321 - 325
  • [49] Identification of 6 cuproptosis-related genes for active ulcerative colitis with both diagnostic and therapeutic values
    Zou, Menglong
    Zhang, Wei
    Zhu, Ying
    Xu, Yin
    MEDICINE, 2023, 102 (43) : E35503
  • [50] Cinobufagin treatments suppress tumor growth by enhancing the expression of cuproptosis-related genes in liver cancer
    Amelimojarad, Mandana
    Amelimojarad, Melika
    Shariati, Parvin
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025, 398 (02) : 1575 - 1582